Global Animal Model Market

Animal Model Market Size, Share, Growth Analysis, By Type(Pigs, Cats, and Mice), By Application(Research and Development, Production, and Quality Control), By End-use(Pharmaceutical & Biotechnology Companies, Academic Research Institute, Contract Research Organization), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35A2418 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 63 | Figures: 75

Animal Model Market Dynamics

Animal model Market Drivers

Increasing Demand for Personalized Medicine

  • With advancements in genomics and precision medicine, there is a need for animal models that can accurately represent individual patient characteristics and response to treatments. Researchers and pharmaceutical companies are increasingly utilizing animal models to study specific genetic variations and develop targeted therapies. For example, the development of patient-derived xenograft (PDX) models, where patient tumor samples are implanted into animals for drug testing, gained momentum in 2022. These models allow researchers to evaluate the efficacy of treatments tailored to individual patients, driving the demand for animal models in personalized medicine.

Advancements in Gene Editing Technologies

  • Another driver in the animal model market in 2022 was the rapid advancement of gene editing technologies, such as CRISPR-Cas9. These technologies allow for precise manipulation of genes in animal models, enabling the creation of genetically modified models that closely mimic human diseases. Researchers can introduce specific genetic mutations or modifications in animal models to study the underlying mechanisms of diseases and develop novel therapeutics. The widespread adoption of gene editing technologies in 2022 contributed to the increased utilization of animal models and drove innovation in the field.

Animal model Market Restraints

Ethical Concerns and Animal Welfare

  • Despite the significant advancements in the animal model field, ethical concerns and animal welfare remained a major restraint in 2022. The use of animals in research raises ethical questions and prompts debates about the humane treatment of animals. Animal welfare regulations and public scrutiny have led to increased scrutiny of the use of animal models, particularly in countries with stringent animal welfare regulations. These concerns and regulations pose challenges to the expansion of the animal model market and encourage the development of alternative technologies and models.

High Costs and Complexities

  • The high costs associated with maintaining animal facilities, purchasing and breeding animals, and conducting experiments with animal models presented a restraint in the market in 2022. Animal models require dedicated facilities, specialized care, and resources, making them expensive to maintain. Additionally, the complexities involved in working with animal models, such as the need for experienced personnel, regulatory compliance, and logistical challenges, add to the overall costs. These cost and complexity factors can limit the accessibility and utilization of animal models, especially for smaller research organizations with limited budgets.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Animal model Market size was valued at USD 2.26 Billion in 2022 and is poised to grow from USD 2.44 Billion in 2023 to USD 4.44 Billion by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The global animal model market is highly competitive and comprises of several key players vying for market share. These companies engage in extensive research and development activities to develop innovative animal models and services to cater to the evolving needs of the pharmaceutical, biotechnology, and academic research sectors. Additionally, strategic collaborations, mergers, and acquisitions are commonly observed in the market as companies aim to strengthen their market presence and expand their product portfolios. The competitive landscape of the animal model market is characterized by intense competition, technological advancements, and a focus on customer-centric solutions. Market players strive to differentiate themselves through high-quality products, comprehensive service offerings, and strong customer support. With the growing demand for reliable and predictive animal models in drug discovery and development, these companies continue to play a crucial role in driving advancements in biomedical research and contributing to the overall growth of the animal model market. 'Charles River Laboratories International Inc. (US)', 'Envigo (US)', 'The Jackson Laboratory (US)', 'Taconic Biosciences Inc. (US)', 'genOway SA (France)', 'Horizon Discovery Group plc (UK)', 'TransGenic Inc. (Japan)', 'Crown Bioscience Inc. (US)', 'Janvier Labs (France)', 'Laboratory Corporation of America Holdings (US)', 'Harbour Antibodies BV (Netherlands)', 'Eurofins Scientific (Luxembourg)', 'Biocytogen LLC (US)', 'Transnetyx Inc. (US)', 'Ingenious Targeting Laboratory (US)', 'Charles River Japan (Japan)', 'Cyagen Biosciences Inc. (US)', 'Ozgene Pty Ltd (Australia)', 'Hera Biolabs Inc. (US)', 'Pharmaron Beijing Co., Ltd. (China)'

With advancements in genomics and precision medicine, there is a need for animal models that can accurately represent individual patient characteristics and response to treatments. Researchers and pharmaceutical companies are increasingly utilizing animal models to study specific genetic variations and develop targeted therapies. For example, the development of patient-derived xenograft (PDX) models, where patient tumor samples are implanted into animals for drug testing, gained momentum in 2022. These models allow researchers to evaluate the efficacy of treatments tailored to individual patients, driving the demand for animal models in personalized medicine.

Shift towards Humanized and Translational Models: A key trend observed in the animal model market in 2022 was the increasing focus on humanized and translational models. Researchers are striving to develop animal models that closely mimic human physiology, disease progression, and drug responses. This trend involves the incorporation of human cells, tissues, or genetic modifications into animal models to enhance their relevance to human diseases. For example, the development of humanized mice with a human immune system allows for better studying of immune-related diseases and testing of immunotherapies. The shift towards humanized and translational models in 2022 highlights the industry's aim to improve the predictability and applicability of animal models in human disease research.

North America emerges as the dominating region in 2022. The region's dominance can be attributed to several factors, including a strong research infrastructure, a well-established pharmaceutical and biotechnology industry, and significant investments in biomedical research. The presence of leading research institutions, universities, and pharmaceutical companies in countries like the United States and Canada contributes to North America's prominence in the animal model market. Moreover, favorable government initiatives and funding for research activities further support the growth of the market in the region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Animal Model Market

Report ID: SQMIG35A2418

$5,300
BUY NOW GET FREE SAMPLE